<p>馬拉松資本管理在第二季度收購了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的新股份，根據該公司在最近向 SEC 提交的文件。該基金收購了 12,054 股公司股票，價值約為 893,000 美元。</p>
<ul>
<li>GE 航空：卡塔爾交易推動數十億美元增長引擎</li>
</ul>
<p>其他一些對沖基金和機構投資者最近也買賣了 GEHC 的股票。先鋒集團在第二季度將其在 GE HealthCare Technologies 的股份增加了 1.4%。先鋒集團目前擁有 52,107,758 股公司股票，價值 3,859,622,000 美元，此前在上個季度又購買了 703,903 股。道奇與考克斯在第二季度將其在 GE HealthCare Technologies 的股份增加了 42.1%。道奇與考克斯目前擁有 23,567,950 股公司股票，價值 1,745,678,000 美元，此前在上個季度又購買了 6,982,441 股。州街公司在第二季度將其在 GE HealthCare Technologies 的持股增加了 1.9%。州街公司目前擁有 19,660,742 股公司股票，價值 1,456,271,000 美元，此前在上個季度又收購了 372,755 股。Geode 資本管理公司在第二季度將其在 GE HealthCare Technologies 的股份增加了 2.0%。Geode 資本管理公司目前擁有 11,944,407 股公司股票，價值 881,060,000 美元，此前在上個季度又收購了 231,302 股。最後，挪威銀行在第二季度收購了 GE HealthCare Technologies 的新股份，價值約為 468,120,000 美元。對沖基金和其他機構投資者目前擁有公司 82.06% 的股票。</p>
<h2>GE HealthCare Technologies 股票上漲 1.7%</h2>
<p>GEHC 週四開盤價為 84.47 美元。GE HealthCare Technologies Inc.的 52 周低點為 57.65 美元，52 周高點為 94.80 美元。該公司的債務與股本比率為 0.83，速動比率為 0.95，流動比率為 1.18。該股票的市值為 384.8 億美元，市盈率為 17.45，PEG 比率為 3.47，貝塔值為 1.10。該公司的 50 日移動平均線為 76.49 美元，200 日移動平均線為 74.79 美元。</p>
<ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
<p>GE HealthCare Technologies（NASDAQ:GEHC - 獲取免費報告）最近於 10 月 29 日星期三發佈了季度財報。該公司報告每股收益為 1.07 美元，超過分析師一致預期的 1.05 美元，超出 0.02 美元。GE HealthCare Technologies 的股本回報率為 22.52%，淨利潤率為 10.94%。該公司在本季度的收入為 51.4 億美元，而分析師預期為 50.7 億美元。在去年同期，該公司每股收益為 1.14 美元。GE HealthCare Technologies 的季度收入同比增長 5.8%。GE HealthCare Technologies 已將其 2025 財年的指導目標設定為每股收益 4.510-4.630 美元。研究分析師平均預計 GE HealthCare Technologies Inc.今年的每股收益為 4.68 美元。</p>
<h2>GE HealthCare Technologies 宣佈分紅</h2>
<p>該公司最近還披露了一項季度分紅，將於 2 月 13 日星期五支付。1 月 9 日的登記投資者將獲得 0.035 美元的分紅。這代表着 0.14 美元的年化分紅和 0.2% 的收益率。該分紅的除息日為 1 月 9 日。GE HealthCare Technologies 的分紅支付比率目前為 2.89%。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>超聲波減肥：GE HealthCare 與諾和諾德的合作</li>
</ul>
<p>GEHC 最近成為多份分析師報告的主題。華爾街 Zen 在 9 月 20 日星期六的一份研究報告中將 GE HealthCare Technologies 的股票評級從 “買入” 下調至 “持有”。Stifel Nicolaus 在 11 月 21 日星期五的一份研究報告中對 GE HealthCare Technologies 設定了 90.00 美元的目標價。Zacks Research 在 9 月 29 日星期一的一份研究報告中將 GE HealthCare Technologies 的評級從 “強烈買入” 下調至 “持有”。巴克萊在 10 月 13 日星期一的一份研究報告中對 GE HealthCare Technologies 的股票進行了覆蓋。他們設定了 “等權重” 評級和 86.00 美元的目標價。最後，摩根士丹利在 10 月 30 日星期四的一份報告中將 GE HealthCare Technologies 的目標價從 74.00 美元上調至 80.00 美元，並給予該股票 “等權重” 評級。六位分析師對該股票給予了買入評級，六位分析師對公司的股票給予了持有評級。根據 MarketBeat 的數據，GE HealthCare Technologies 目前的共識評級為 “適度買入”，共識目標價為 86.45 美元。</p>
<p><strong>獲取我們關於 GE HealthCare Technologies 的最新報告</strong></p>
<h2>GE HealthCare Technologies 公司簡介</h2>
<p>（免費報告）</p>
<p>GE HealthCare Technologies Inc.從事產品、服務和補充數字解決方案的開發、製造和營銷，這些產品、服務和解決方案用於美國、加拿大及國際上患者的診斷、治療和監測。該公司通過四個部門運營：成像、超聲、患者護理解決方案和藥物診斷。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票比 GE HealthCare Technologies 更好</li>
<li>S&amp;P/TSX 指數是什麼？</li>
<li>GameStop 看起來崩潰：為什麼 GME 可能在 2026 年崩盤</li>
<li>經濟報告在成功投資策略中的作用</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>現在購買的 3 只巨型成長股</li>
<li>3 個理由説明 Casey’s General Stores 將繼續上漲</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
<p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 GE HealthCare Technologies 並不在名單上。</p>
<p>雖然 GE HealthCare Technologies 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

GEHC

<p>馬拉松資本管理公司收購了 12,054 股 GE HealthCare Technologies，價值 89.3 萬美元。其他機構投資者也增加了他們的持倉。GEHC 的股票開盤價為 84.47 美元，市值為 384.8 億美元。分析師的評級不一，有些將評級下調至 “持有”，而其他則將目標價設定在 80 至 90 美元之間。GEHC 報告的季度每股收益為 1.07 美元，超出預期，並宣佈每股派息 0.035 美元</p>

<p>Marathon Capital Management acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 12,054 shares of the company's stock, valued at approximately $893,000.</p>
<div class="lb-trans"><p>馬拉松資本管理在第二季度收購了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免費報告）的新股份，根據該公司在最近向 SEC 提交的文件。該基金收購了 12,054 股公司股票，價值約為 893,000 美元。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空：卡塔爾交易推動數十億美元增長引擎</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors also recently bought and sold shares of GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company's stock worth $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter. Dodge &amp; Cox increased its position in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge &amp; Cox now owns 23,567,950 shares of the company's stock valued at $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. State Street Corp boosted its holdings in GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company's stock worth $1,456,271,000 after acquiring an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 2.0% during the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company's stock worth $881,060,000 after acquiring an additional 231,302 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of GE HealthCare Technologies during the second quarter valued at about $468,120,000. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者最近也買賣了 GEHC 的股票。先鋒集團在第二季度將其在 GE HealthCare Technologies 的股份增加了 1.4%。先鋒集團目前擁有 52,107,758 股公司股票，價值 3,859,622,000 美元，此前在上個季度又購買了 703,903 股。道奇與考克斯在第二季度將其在 GE HealthCare Technologies 的股份增加了 42.1%。道奇與考克斯目前擁有 23,567,950 股公司股票，價值 1,745,678,000 美元，此前在上個季度又購買了 6,982,441 股。州街公司在第二季度將其在 GE HealthCare Technologies 的持股增加了 1.9%。州街公司目前擁有 19,660,742 股公司股票，價值 1,456,271,000 美元，此前在上個季度又收購了 372,755 股。Geode 資本管理公司在第二季度將其在 GE HealthCare Technologies 的股份增加了 2.0%。Geode 資本管理公司目前擁有 11,944,407 股公司股票，價值 881,060,000 美元，此前在上個季度又收購了 231,302 股。最後，挪威銀行在第二季度收購了 GE HealthCare Technologies 的新股份，價值約為 468,120,000 美元。對沖基金和其他機構投資者目前擁有公司 82.06% 的股票。</p>
</div><h2>GE HealthCare Technologies Stock Up 1.7%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上漲 1.7%</h2>
</div><p>GEHC opened at $84.47 on Thursday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The stock has a market capitalization of $38.48 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 3.47 and a beta of 1.10. The company has a fifty day moving average of $76.49 and a two-hundred day moving average of $74.79.</p>
<div class="lb-trans"><p>GEHC 週四開盤價為 84.47 美元。GE HealthCare Technologies Inc.的 52 周低點為 57.65 美元，52 周高點為 94.80 美元。該公司的債務與股本比率為 0.83，速動比率為 0.95，流動比率為 1.18。該股票的市值為 384.8 億美元，市盈率為 17.45，PEG 比率為 3.47，貝塔值為 1.10。該公司的 50 日移動平均線為 76.49 美元，200 日移動平均線為 74.79 美元。</p>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion during the quarter, compared to analysts' expectations of $5.07 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies's quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（NASDAQ:GEHC - 獲取免費報告）最近於 10 月 29 日星期三發佈了季度財報。該公司報告每股收益為 1.07 美元，超過分析師一致預期的 1.05 美元，超出 0.02 美元。GE HealthCare Technologies 的股本回報率為 22.52%，淨利潤率為 10.94%。該公司在本季度的收入為 51.4 億美元，而分析師預期為 50.7 億美元。在去年同期，該公司每股收益為 1.14 美元。GE HealthCare Technologies 的季度收入同比增長 5.8%。GE HealthCare Technologies 已將其 2025 財年的指導目標設定為每股收益 4.510-4.630 美元。研究分析師平均預計 GE HealthCare Technologies Inc.今年的每股收益為 4.68 美元。</p>
</div><h2>GE HealthCare Technologies Announces Dividend</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies's dividend payout ratio is currently 2.89%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度分紅，將於 2 月 13 日星期五支付。1 月 9 日的登記投資者將獲得 0.035 美元的分紅。這代表着 0.14 美元的年化分紅和 0.2% 的收益率。該分紅的除息日為 1 月 9 日。GE HealthCare Technologies 的分紅支付比率目前為 2.89%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超聲波減肥：GE HealthCare 與諾和諾德的合作</li>
</ul>
</div><p>GEHC has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of GE HealthCare Technologies from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, September 20th. Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a research note on Friday, November 21st. Zacks Research lowered GE HealthCare Technologies from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an &#34;equal weight&#34; rating and a $86.00 price objective for the company. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $86.45.</p>
<div class="lb-trans"><p>GEHC 最近成為多份分析師報告的主題。華爾街 Zen 在 9 月 20 日星期六的一份研究報告中將 GE HealthCare Technologies 的股票評級從 “買入” 下調至 “持有”。Stifel Nicolaus 在 11 月 21 日星期五的一份研究報告中對 GE HealthCare Technologies 設定了 90.00 美元的目標價。Zacks Research 在 9 月 29 日星期一的一份研究報告中將 GE HealthCare Technologies 的評級從 “強烈買入” 下調至 “持有”。巴克萊在 10 月 13 日星期一的一份研究報告中對 GE HealthCare Technologies 的股票進行了覆蓋。他們設定了 “等權重” 評級和 86.00 美元的目標價。最後，摩根士丹利在 10 月 30 日星期四的一份報告中將 GE HealthCare Technologies 的目標價從 74.00 美元上調至 80.00 美元，並給予該股票 “等權重” 評級。六位分析師對該股票給予了買入評級，六位分析師對公司的股票給予了持有評級。根據 MarketBeat 的數據，GE HealthCare Technologies 目前的共識評級為 “適度買入”，共識目標價為 86.45 美元。</p>
</div><p><strong>Get Our Latest Report on GE HealthCare Technologies</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 GE HealthCare Technologies 的最新報告</strong></p>
</div><h2>GE HealthCare Technologies Company Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p>
<div class="lb-trans"><p>GE HealthCare Technologies Inc.從事產品、服務和補充數字解決方案的開發、製造和營銷，這些產品、服務和解決方案用於美國、加拿大及國際上患者的診斷、治療和監測。該公司通過四個部門運營：成像、超聲、患者護理解決方案和藥物診斷。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>What is the S&amp;P/TSX Index?</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
<li>The Role Economic Reports Play in a Successful Investment Strategy</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 GE HealthCare Technologies 更好</li>
<li>S&amp;P/TSX 指數是什麼？</li>
<li>GameStop 看起來崩潰：為什麼 GME 可能在 2026 年崩盤</li>
<li>經濟報告在成功投資策略中的作用</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>現在購買的 3 只巨型成長股</li>
<li>3 個理由説明 Casey’s General Stores 將繼續上漲</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 GE HealthCare Technologies 並不在名單上。</p>
</div><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 GE HealthCare Technologies 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

馬拉松資本管理公司在 GE HealthCare Technologies Inc.（GE HealthCare Tech）中建立了頭寸